GlassScriptPhysician profile
Stacy H Weiss
NPI 1902806086
$4,220.05
in general payments reported to CMS, 2019-2025
41 companies · $584 in 2025
The $584 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $407 · 2020: $425 · 2021: $822 · 2022: $565 · 2023: $643 · 2024: $775 · 2025: $584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,000.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $574.40 | 2019-2024 | Orilissa, Lo Loestrin Fe |
| Amgen INC. | $430.56 | 2019-2025 | Evenity, Prolia, Prolia |
| Shield Therapeutics INC | $358.39 | 2023-2024 | Accrufer |
| Therapeuticsmd, INC. | $289.47 | 2021-2022 | |
| Hologic Sales and Service, LLC | $272.78 | 2019-2025 | Myosure Tissue Removal Device, Coolseal Generator, Aptima |
| Organon LLC | $228.57 | 2021-2025 | Nexplanon, Nuvaring |
| Amneal Pharmaceuticals LLC | $163.58 | 2021-2025 | Unithroid |
| Radius Health, INC. | $154.61 | 2023-2025 | Tymlos |
| Exeltis, USA INC. | $150.33 | 2021-2025 | Slynd |
| Pfizer INC. | $147.32 | 2019-2024 | |
| Aspira Women'S Health INC | $139.59 | 2022 | |
| Astellas Pharma US INC | $125.72 | 2019-2025 | Veozah |
| Avion Pharmaceuticals | $116.38 | 2020-2023 | Balcoltra |
| Lupin INC. | $102.57 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.06 | 2019-2025 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.